Coloplast starts share buyback program

The Danish medtech company has initiated a buyback of its own shares worth up to DKK 500m (USD 76.4m)
Photo: Coloplast / PR
Photo: Coloplast / PR
by marketwire, translated by catherine brett

In connection with the release of its 2021 full-year report, Coloplast announced that it would be starting a share buyback program totaling up to DKK 500m (USD 76.4m).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading